A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease

Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors

Ulrich Laufs, Vito La Fata, Jorge Plutzky et al. · Circulation · 1998 · 1.8K citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.

Mark T. Quinn, Srinivasan Parthasarathy, Loren G. Fong et al. · Proceedings of the National Academy of Sciences · 1987 · 1.1K citations · Full text

Life Sciences, Biochemistry, Physiology +17

Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month

G. O’Driscoll, Roger R. Taylor · Circulation · 1997 · 957 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

Octavio Hernández‐Perera, Dolores Pérez‐Sala, R. Sánchez-Pascuala et al. · Journal of Clinical Investigation · 1998 · 764 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +12

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

Modification of Diet in Renal Disease Study Group, Lawrence G. Hunsicker, Sharon G. Adler et al. · Kidney International · 1997 · 698 citations · Full text

Medicine, Nephrology, Nutritional Sciences +9